Basis of Presentation and Liquidity (Details Narrative) - USD ($)				1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 04, 2022	Feb. 01, 2022	Sep. 09, 2018	Feb. 28, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2021
Accumulated deficit					$ 137,692,000			$ 135,725,000
Allowance for doubtful accounts receivable					1,000			$ 1,000
Depreciation					17,000	$ 7,000
SRP purchase agreement [Member]
Number of shares sold in transaction		600,000
SRP Purchase Agreement Closing [Member]
Number of shares sold in transaction	100,003	100,003
Specialty Renal Products, Inc. [Member] | Loan Agreement [Member]
Repayments of debt					1,300,000
Proceeds from Loans							$ 1,000,000.0
Loans payable					$ 1,300,000
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member]
Ownership percentage	62.50%
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member] | Lambda investors LLC [Member]
Ownership percentage	36.00%
Number of shares issued	25,938
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member] | Chief Executive Officer [Member]
Number of shares issued	313
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member] | SRP purchase agreement [Member]
Number of shares sold in transaction			600,000	100,003
Share price			$ 5.00
Gross proceeds received through transaction	$ 500,015		$ 3,000,000.0
Number of shares issued	62,500
Specialty Renal Products, Inc. [Member] | Series A Preferred Stock [Member] | SRP Purchase Agreement Closing [Member]
Number of shares sold in transaction	100,003
Specialty Renal Products, Inc. [Member] | Private Placement [Member]
Ownership percentage					37.50%